VJHemOnc is committed to improving our service to you

SOHO 2020 | ALL patients & allo-HSCT

VJHemOnc is committed to improving our service to you

Josep M. Ribera

Josep M. Ribera, MD, PhD, Germans Trias i Pujol University Hospital, Barcelona, Spain, discusses his talk in Society of Hematologic Oncology (SOHO) 2020 on which acute lymphoblastic leukemia (ALL) patients should receive an allogeneic hematopoietic stem cell transplant (allo-HSCT) in first complete remission. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter